This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Radiology clinician, educator, and mentor Lawrence Ross Muroff, MD, died on March 27. He was 82. He was thoughtful, caring, and charming, according to an obituary posted by Segal Funeral Home, and throughout his life, he combined "entrepreneurial, academic/technical, and interpersonal skills to inspire others." Lawrence Muroff, MD. Segal Funeral Home Muroff earned an undergraduate degree in sociology at Dartmouth College (1964) and his medical degree at Harvard Medical School (1967).
In this previous post about breast imaging , we briefly touched on the soon-to-be-growing-and-maybe-even-critical problem of automation bias in radiology caused by the growing use of AI. We see similar findings in this study evaluating AI-assisted detection of cerebral aneurysms : Results False-positive AI results led to significantly higher suspicion of aneurysm findings (p=0.01).
GE HealthCare has purchased full ownership of Japanese radiopharmaceutical developer Nihon Medi-Physics (NMP) from Sumitomo Chemical. The vendor had previously held a 50% stake in NMP, which has a product portfolio that includes GE HealthCares Vizamyl amyloid visualization radiotracer, DaTSCAN agent for Parkinsons diagnosis, and Myoview SPECT myocardial perfusion imaging agent.
Amidst rising cancer prevalence and soaring costs, new cancer technologies and innovations are emerging to support the early detection, treatment, and surveillance of cancer. Read this guide to understand how to evaluate these solutions for your employees and members – and to learn more about the current state of coverage, clinical and cost effectiveness, and impact on quality and outcomes.
Scottsdale, AZ-based outpatient medical imaging provider SimonMed Imaginghas confirmed that it experienced a data breach in January and will issue notices about the event to affected individuals. The company was alerted by one of its vendors of a "security incident" on January 27. It reviewed its systems, discovered suspicious activity, and began an investigation.
ACR said March 27 that it will "continue to advocate for federal funding for radiology research and encourage imaging as a priority to the healthcare leaders.
ORLANDO Ultrasounds use in the therapeutic space is rising and may provide key advantages over current standards of care for neuropathologies. That was the take-home message from a keynote presentation given at the American Institute of Ultrasound in Medicine (AIUM) annual meeting on March 31 by Ali Rezai, MD, from West Virginia University. Rezai, who is leading efforts in this area, discussed current and potential applications of therapeutic soundwaves in medicine.
Breast cancer is the second most common cancer in women in the U.S. (skin cancers are first), accounting for around 30% of all new female cancers yearly. 1 And 2025 will be no exception. The American Cancer Society estimates nearly 317,000 new cases of invasive breast cancer and about 59,000 new cases of ductal carcinoma in situ (DCIS), with more than 42,000 estimated deaths. 1 So, how are these cancers detected?
Patient-centric scheduling can only be achieved through optimized radiology workflows, effective communications between staff and physicians, and, of course, through specialized schedulers. In this guide, we’ll take you through a step-by-step process to transform your radiology center into a high-performance hub of medical imaging.
The Scottsdale, Arizona-based radiology practice issued a notice to impacted parties on March 28 after reports of the hack first started surfacing in mid-February.
Bottom Line Up Top: A negative D-Dimer likely excludes significant pulmonary embolism (PE) in all patients but the low chance of getting a negative result makes a D-Dimer first approach of low clinical utility in the high pre-test probability group. Clinical Scenario: A 45-year-old man with malignant melanoma presents with right-sided pleuritic chest pain for 3 days.
QT Imaging has posted Q4 and year-end revenue increases. For the period (end-December 31, 2024), the company reported fourth-quarter revenue of $847,000, compared with $5,000 in the same period for 2023. For the year, the company reported revenue of $4.9 million compared with $40,000 in 2023. For the quarter, QT Imaging posted a net loss of $3.5 million, compared with a net loss of $1.5 million in 2023.
About 40% of us will be diagnosed with cancer in our lifetime, and patients are getting younger. At the same time, the cost of treatment continues to rise, with employers spending 8.5% more on cancer care for each employee than they did last year. The best thing employers can do for their employees and business tomorrow is to invest in cancer detection and care today.
AZmed has received two clearances from the U.S. Food and Drug Administration (FDA) for its AI software, AZchest. The clearances include applications intended to assist radiologists in the interpretation and detection of chest x-rays for lung nodules and triage capabilities for pneumothorax and pleural effusion, according to the firm. Research has found that AZchest has a sensitivity for detecting lung nodules of 88.5% and a specificity of 82.9%, AZmed said, and its sensitivity for pneumothorax a
For patients with no-option chronic limb-threatening ischemia (CLTI), transcatheter arterialization provided over a 25 percent higher amputation-free survival rate over standard medical management at one year, according to research presented at the Society of Interventional Radiology (SIR) Annual Scientific Meeting.
A Los Angeles-area radiology group has agreed to pay nearly $2.4 million as part of a $62.8 million whistleblower False Claims Act lawsuit involving higher-paying diagnoses codes and radiology report addenda to support them, according to the U.S. Attorney's Office in the Central District of California. Renaissance Imaging Medical Associates (RIMA), a Northridge-based radiology group, worked with Seoul Medical Group and its subsidiary Advanced Medical Management, headquartered in the Koreatown ar
Discover how Color's comprehensive care solution is revolutionizing cancer screening adherence and knowledge. Through an in-depth case study, Color's unique approach to comprehensive cancer care has shown significant benefits in increasing screening rates and enhancing patient knowledge. Participants reported a 2-3x increase in adherence to screening guidelines over just 8 weeks, with 84% of participants increasing their familiarity with timing and frequency of cancer screening.
An AI tool designed for coronary CT angiography can identify women at high risk for major adverse cardiovascular events (MACE), according to a study published March 31 in Circulation: Cardiovascular Imaging. The finding is from an analysis involving 3,551 patients that used a commercially available tool (AI-QCT, Cleerly), with features from the tool conferring a higher relative risk of MACE in women than men, noted lead author Gudrun Feuchtner, MD, of the Medical University of Innsbruck in Austr
LI-RADS category 5 (LR-5) assessment had an 11 percent higher AUC for detecting hepatocellular carcinoma (HCC) in patients with non-cirrhotic chronic hepatitis C (CHC) in comparison to those with cirrhotic CHC.
Explore the latest insights from the American Cancer Society's “Cancer Statistics 2024” report, which unveils multiple alarming trends in cancer data. Cancer is on the rise among young adults, and diagnoses for 6 of the 10 most common cancers are escalating. With over 2 million new cancer cases projected in the U.S. this year, employers face increased challenges when it comes to supporting employees.
We organize all of the trending information in your field so you don't have to. Join 5,000 users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
165 
Let's personalize your content